Literature DB >> 25776222

Recent Advances and the Future of Stem Cell Therapies in Amyotrophic Lateral Sclerosis.

Stephen A Goutman1, Kevin S Chen, Eva L Feldman.   

Abstract

Amyotrophic lateral sclerosis is a progressive neurodegenerative disease of the motor neurons without a known cure. Based on the possibility of cellular neuroprotection and early preclinical results, stem cells have gained widespread enthusiasm as a potential treatment strategy. Preclinical models demonstrate a protective role of engrafted stem cells and provided the basis for human trials carried out using various types of stem cells, as well as a range of cell delivery methods. To date, no trial has demonstrated a clear therapeutic benefit; however, results remain encouraging and are the basis for ongoing studies. In addition, stem cell technology continues to improve, and induced pluripotent stem cells may offer additional therapeutic options in the future. Improved disease models and clinical trials will be essential in order to validate stem cells as a beneficial therapy.

Entities:  

Mesh:

Year:  2015        PMID: 25776222      PMCID: PMC4404436          DOI: 10.1007/s13311-015-0339-9

Source DB:  PubMed          Journal:  Neurotherapeutics        ISSN: 1878-7479            Impact factor:   7.620


  126 in total

1.  Distribution, differentiation, and survival of intravenously administered neural stem cells in a rat model of amyotrophic lateral sclerosis.

Authors:  Dinko Mitrecić; Charles Nicaise; Srećko Gajović; Roland Pochet
Journal:  Cell Transplant       Date:  2010-03-26       Impact factor: 4.064

2.  Olfactory ensheathing cell neurorestorotherapy for amyotrophic lateral sclerosis patients: benefits from multiple transplantations.

Authors:  Lin Chen; Di Chen; Haitao Xi; Qingmiao Wang; Yancheng Liu; Feng Zhang; Hongmei Wang; Yushui Ren; Juan Xiao; Yuanchao Wang; Hongyun Huang
Journal:  Cell Transplant       Date:  2012       Impact factor: 4.064

Review 3.  Translational stem cell therapy for amyotrophic lateral sclerosis.

Authors:  Nicholas M Boulis; Thais Federici; Jonathan D Glass; J Simon Lunn; Stacey A Sakowski; Eva L Feldman
Journal:  Nat Rev Neurol       Date:  2011-12-13       Impact factor: 42.937

4.  Positive effect of transplantation of hNT neurons (NTera 2/D1 cell-line) in a model of familial amyotrophic lateral sclerosis.

Authors:  Svitlana Garbuzova-Davis; Alison E Willing; Melissa Milliken; Samuel Saporta; Tanya Zigova; David W Cahill; Paul R Sanberg
Journal:  Exp Neurol       Date:  2002-04       Impact factor: 5.330

5.  Adult olfactory bulb neural precursor cell grafts provide temporary protection from motor neuron degeneration, improve motor function, and extend survival in amyotrophic lateral sclerosis mice.

Authors:  Lee J Martin; Zhiping Liu
Journal:  J Neuropathol Exp Neurol       Date:  2007-11       Impact factor: 3.685

6.  Stem cell transplantation in amyotrophic lateral sclerosis patients: methodological approach, safety, and feasibility.

Authors:  Héctor R Martínez; Juan Francisco Molina-Lopez; María Teresa González-Garza; Jorge E Moreno-Cuevas; Enrique Caro-Osorio; Alfonso Gil-Valadez; Eugenio Gutierrez-Jimenez; Oscar E Zazueta-Fierro; J Alfonso Meza; Patricio Couret-Alcaraz; Martin Hernandez-Torre
Journal:  Cell Transplant       Date:  2012       Impact factor: 4.064

7.  Human neural stem cell grafts in the spinal cord of SOD1 transgenic rats: differentiation and structural integration into the segmental motor circuitry.

Authors:  Leyan Xu; David K Ryugo; Tan Pongstaporn; Karl Johe; Vassilis E Koliatsos
Journal:  J Comp Neurol       Date:  2009-06-01       Impact factor: 3.215

8.  Origin and distribution of bone marrow-derived cells in the central nervous system in a mouse model of amyotrophic lateral sclerosis.

Authors:  Jennifer N Solomon; Coral-Ann B Lewis; Bahareh Ajami; Stephane Y Corbel; Fabio M V Rossi; Charles Krieger
Journal:  Glia       Date:  2006-05       Impact factor: 7.452

9.  Induction of bone marrow stromal cells to neurons: differentiation, transdifferentiation, or artifact?

Authors:  Paul Lu; Armin Blesch; Mark H Tuszynski
Journal:  J Neurosci Res       Date:  2004-07-15       Impact factor: 4.164

10.  Stem-cell transplantation into the frontal motor cortex in amyotrophic lateral sclerosis patients.

Authors:  Hector R Martinez; Maria T Gonzalez-Garza; Jorge E Moreno-Cuevas; Enrique Caro; Eugenio Gutierrez-Jimenez; Jose J Segura
Journal:  Cytotherapy       Date:  2009       Impact factor: 5.414

View more
  9 in total

Review 1.  Intraspinal stem cell transplantation for amyotrophic lateral sclerosis.

Authors:  Kevin S Chen; Stacey A Sakowski; Eva L Feldman
Journal:  Ann Neurol       Date:  2016-02-12       Impact factor: 10.422

2.  The Spectrum of Motor Neuron Diseases: From Childhood Spinal Muscular Atrophy to Adult Amyotrophic Lateral Sclerosis.

Authors:  Stacey A Sakowski; Eva L Feldman
Journal:  Neurotherapeutics       Date:  2015-04       Impact factor: 7.620

3.  Cell-based therapies for amyotrophic lateral sclerosis/motor neuron disease.

Authors:  S Fadilah Abdul Wahid; Zhe Kang Law; Nor Azimah Ismail; Nai Ming Lai
Journal:  Cochrane Database Syst Rev       Date:  2019-12-19

Review 4.  Economic Studies in Motor Neurone Disease: A Systematic Methodological Review.

Authors:  Alan Moore; Carolyn A Young; Dyfrig A Hughes
Journal:  Pharmacoeconomics       Date:  2017-04       Impact factor: 4.981

Review 5.  Stem cell treatments for amyotrophic lateral sclerosis: a critical overview of early phase trials.

Authors:  Stephen A Goutman; Masha G Savelieff; Stacey A Sakowski; Eva L Feldman
Journal:  Expert Opin Investig Drugs       Date:  2019-06-12       Impact factor: 6.206

Review 6.  Role of Neuroinflammation in Amyotrophic Lateral Sclerosis: Cellular Mechanisms and Therapeutic Implications.

Authors:  Jia Liu; Fei Wang
Journal:  Front Immunol       Date:  2017-08-21       Impact factor: 7.561

7.  Long-term Phase 1/2 intraspinal stem cell transplantation outcomes in ALS.

Authors:  Stephen A Goutman; Morton B Brown; Jonathan D Glass; Nicholas M Boulis; Karl Johe; Tom Hazel; Merit Cudkowicz; Nazem Atassi; Lawrence Borges; Parag G Patil; Stacey A Sakowski; Eva L Feldman
Journal:  Ann Clin Transl Neurol       Date:  2018-05-02       Impact factor: 4.511

Review 8.  Uses for humanised mouse models in precision medicine for neurodegenerative disease.

Authors:  Remya R Nair; Silvia Corrochano; Samanta Gasco; Charlotte Tibbit; David Thompson; Cheryl Maduro; Zeinab Ali; Pietro Fratta; Abraham Acevedo Arozena; Thomas J Cunningham; Elizabeth M C Fisher
Journal:  Mamm Genome       Date:  2019-06-15       Impact factor: 2.957

9.  PuraMatrix hydrogel enhances the expression of motor neuron progenitor marker and improves adhesion and proliferation of motor neuron-like cells.

Authors:  Marzieh Darvishi; Hatef Ghasemi Hamidabadi; Sajad Sahab Negah; Ardeshir Moayeri; Taki Tiraihi; Javad Mirnajafi-Zadeh; Ali Jahanbazi Jahan-Abad; Amir Shojaei
Journal:  Iran J Basic Med Sci       Date:  2020-04       Impact factor: 2.699

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.